2014
DOI: 10.7314/apjcp.2014.15.16.6597
|View full text |Cite
|
Sign up to set email alerts
|

Five Year Survival of Women with Breast Cancer in Yazd

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
19
2

Year Published

2015
2015
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(23 citation statements)
references
References 20 publications
2
19
2
Order By: Relevance
“…In this study the mean age of women at the time of diagnosis was 48.51±11.81 years and there was no significant difference between 5 intervals of studies, and in the study of Hemminki the mean age of women with breast cancer was 46.3 years (Hemminki et al, 2011). In the study of Fallahzadeh indicated that the mean age at diagnosis was 48.2±11.7 year, similar to other Iranian study such as Afsharfard and Najafi (Afsharfard et al, 2013, Fallahzadeh et al, 2014. The 20-year study of breast cancer in Tehran demonstrated a significant difference for the mean age (47.2, 48.8, 49.2 years) at time intervals respectively (1985-1995, 1996-2000 and 2001-2006) (Harirchi et al, 2010).…”
Section: Discussionsupporting
confidence: 81%
“…In this study the mean age of women at the time of diagnosis was 48.51±11.81 years and there was no significant difference between 5 intervals of studies, and in the study of Hemminki the mean age of women with breast cancer was 46.3 years (Hemminki et al, 2011). In the study of Fallahzadeh indicated that the mean age at diagnosis was 48.2±11.7 year, similar to other Iranian study such as Afsharfard and Najafi (Afsharfard et al, 2013, Fallahzadeh et al, 2014. The 20-year study of breast cancer in Tehran demonstrated a significant difference for the mean age (47.2, 48.8, 49.2 years) at time intervals respectively (1985-1995, 1996-2000 and 2001-2006) (Harirchi et al, 2010).…”
Section: Discussionsupporting
confidence: 81%
“…The above order differs from that of previous similar studies performed in Iran, where stomach cancer ranked the first national cause of YLL, and lung cancer ranked the third provincial and the fourth national cause (Naghavi et al, 2009 cancer, diagnosis at the advanced stages of the disease (Harirchi et al, 2005;Miller et al, 2015), and a survival rate of 5years in 70% of cases (Fallahzadeh et al, 2014) have led to higher YLL due to premature death from breast cancer in Yazdi women. Given resource constraints, therefore, the disease can be detected at early stages through training self-examination and screening by trained general physicians (Hassan et al, 2015).…”
Section: Discussioncontrasting
confidence: 64%
“…Breast cancer (BC) is the most prevalent malignancy in women in both developed and less-developed countries [1][2][3][4][5][6][7][8][9]. In 2012, 1.67 million new cases were diagnosed worldwide, representing 25% of all cancers [10].…”
Section: Introductionmentioning
confidence: 99%